您当前所在的位置:首页 > 产品中心 > 产品信息
Methylprednisolone_分子结构_CAS_83-43-2)
点击图片或这里关闭

Methylprednisolone

产品号 DB00959 公司名称 DrugBank
CAS号 83-43-2 公司网站 http://www.ualberta.ca/
分子式 C22H30O5 电 话 (780) 492-3111
分子量 374.4706 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 835

产品价格信息

请登录

产品别名

标题
Methylprednisolone
IUPAC标准名
(1S,2R,8S,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,8,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
IUPAC传统名
methylprednisolone
商标名
Firmacort
Besonia
Metrisone
Medrol Dosepak
Solomet
Mesopren
Dopomedrol
Medesone
Medlone 21
Medrol Adt Pak
Metrocort
Metysolon
Reactenol
Urbason
Artisone-Wyeth
Esametone
Lemod
Medixon
Medrate
Medrone
Metastab
Metilbetasone
Moderin
Nirypan
Noretona
Predni N Tablinen
Promacortine
Sieropresol
Summicort
Suprametil
Urbasone
Wyacort
别名
Methylprednisolon
Methylprednisolonum [INN-Latin]
Metilprednisolona [INN-Spanish]
Methyleneprednisolone
Metilprednisolone [Dcit]
6alpha-Methylprednisolone

产品登记号

PubChem SID 46504885
PubChem CID 6741
CAS号 83-43-2

产品性质

疏水性(logP) 1.5
溶解度 120 mg/L

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description A prednisolone derivative with similar anti-inflammatory action. [PubChem]
Indication Adjunctive therapy for short-term administration in rheumatoid arthritis.
Pharmacology Methylprednisolone and its derivatives, methylprednisolone sodium succinate and methylprednisolone acetate, are synthetic glucocorticoids used as antiinflammatory or immunosuppressive agents.
Toxicity LD50=2000 mg/kg (orally in rat)
Affected Organisms
Humans and other mammals
Biotransformation Hepatic
Absorption Oral bioavailability 80-99%
Half Life 1-3 hours
Protein Binding 78%
References
Sloka JS, Stefanelli M: The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler. 2005 Aug;11(4):425-32. [Pubmed]
External Links
Wikipedia
RxList
Drugs.com

参考文献

  • Sloka JS, Stefanelli M: The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler. 2005 Aug;11(4):425-32. Pubmed